PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine, Ota and Jinemed Hospital, Istanbul, Turkey.\', \'Department of Rheumatology, Meram Tip Faculty, Necmettin Erbakan University, Konya, Turkey.\', \'Department of Biochemistry, Private Kucukcekmece Hospital, Istanbul, Turkey.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.4103/ijp.IJP_615_20
?:hasPublicationType
?:journal
  • Indian journal of pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 34169908
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.412
?:rankingScore_hIndex
  • 49
is ?:relation_isRelatedTo_publication of
?:title
  • Can emapalumab be life saving for refractory, recurrent, and progressive cytokine storm caused by COVID-19, which is resistant to anakinra, tocilizumab, and Janus kinase inhibitors.
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34169908>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34169908>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all